CGMM Capital Group U.S. Small and Mid Cap ETF
Profitability Metrics
Valuation Metrics
Growth & Cash Flow
Price Change
Top 10 Holdings
| Stock Ticker | Weight |
|---|---|
| USFD | 2.94% |
| EXC | 2.22% |
| MTN | 2.21% |
| LKQ | 2.17% |
| RNR | 2.11% |
| BRO | 1.98% |
| FIX | 1.93% |
| INGM | 1.71% |
| YUM | 1.62% |
| CIEN | 1.60% |
ETF Analysis
Fund Overview
Capital Group U.S. Small and Mid Cap ETF (CGMM) currently reports 106 stock positions (subject to change), placing it in the highly diversified range by holdings breadth. The top line-up is USFD (2.94%), EXC (2.22%), MTN (2.21%), with USFD as the largest single weight at 2.94%. Together, the top three holdings account for 7.37%, which implies a more democratized weight structure where the broader holding set matters as much as the leadership group. This structure gives the portfolio a dual character: meaningful exposure to its highest-conviction names, alongside enough breadth to dampen idiosyncratic noise.
Profitability & Capital Efficiency
Examining the portfolio through a capital allocation lens, ROIC is 10.26%, WACC is 9.02%, and the economic spread is 1.23%. On balance, holdings are generating returns above their cost of capital, though the margin is slim enough to warrant attention. Supporting metrics show ROE at 10.76% and ROA at 5.09%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio that is value-creative but with less room for execution slippage.
Valuation
Turning to how the market is pricing the underlying earnings, trailing P/E of 22.44, forward P/E of 17.19, PEG of 2.28. A moderate trailing-to-forward spread implies earnings growth is anticipated, though the scale of expected improvement is not dramatic. A PEG in this range suggests valuation is fair rather than compelling — the portfolio is priced adequately for its growth, with limited buffer for downside revisions. The aggregate current ratio of 2.68 reflects a holding set with strong liquidity buffers against short-term stress. The combined picture across P/E, forward P/E, PEG, and current ratio suggests a portfolio that is priced for continued execution — where disappointment would be costly and outperformance would likely require positive earnings surprises.
Margins & Cash Generation
From gross to free cash flow, gross margin sits at 42.32%, operating margin at 15.32%, and free cash flow margin at 16.70%. At this gross margin level, the holdings demonstrate adequate production efficiency without commanding premium pricing. The operating margin reading is healthy — adequate to support reinvestment without sacrificing profitability. The portfolio's FCF margin is above average, pointing to holdings with efficient capital deployment and durable cash generation. The margin profile warrants careful consideration — businesses with compressed margins have less room to absorb cost pressure or revenue softness.
Growth & Forward Outlook
Combining revenue momentum with analyst targets, the estimated 12-month price change of 18.93%, where consensus expectations favor gradual appreciation over the next year, while TTM revenue growth of 18.26% reflecting moderate but reliable revenue progress across the basket. Separating operating reality from market-implied expectations is useful here — they can diverge meaningfully when sentiment shifts. The forward return case hinges on whether the operating reality stays close enough to analyst assumptions for those targets to remain credible. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.
Conclusion
BuyThe fundamental case holds up across most key dimensions — the combination of positive economic spread, reasonable valuation, and analyst support is constructive.
This assessment reflects quantitative metrics only and does not constitute financial advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.